Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.

Enabled by a new high-resolution mapping technique, the findings overturn a long-held belief that the genome loses its 3D structure when cells divide.

The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.

A research team in Japan has developed an innovative system that can accurately detect genetic mutations in brain tumors within just 25 minutes. Genetic mutations are crucial markers for diagnosis of brain tumors.

A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.

Three scientists won the Nobel Prize in medicine Monday for discoveries about how the immune system knows to attack germs and not our own bodies.